R01AG078958
Project Grant
Overview
Grant Description
The Role of Retrotransposons in Female Reproductive Aging - Project Summary
Nearly 40% of the mammalian genome originates from retrotransposons. Most mammalian retrotransposons are strictly silenced in development and physiology. However, induction of specific retrotransposons can be observed in normal oocytes and preimplantation embryos. Interestingly, a subset of retrotransposons confers a gene regulatory role, at least in part, by acting as alternative promoters, exons, and polyadenylation signals to regulate proximal protein-coding genes. Such retrotransposon-dependent gene regulation frequently alters gene structure and/or gene expression and has been shown in our preliminary studies to play important developmental functions in oocyte biology and preimplantation development.
Female reproductive aging presents an excellent experimental system to probe the functional importance of retrotransposons in aging. Unlike somatic tissues, which strongly repress retrotransposon expression, oocytes and preimplantation embryos exhibit a strong induction of specific retrotransposons, possibly due to extensive epigenetic reprogramming during these unique developmental stages. Our preliminary studies show that aged oocytes exhibit expression alteration of specific retrotransposons, as well as RT:gene isoforms. Interestingly, the IAPEY4 family, which is retrotransposition-competent, is strongly induced in aged oocytes. IAPEY4 induction could lead to DNA damage and innate immune response in aged oocytes as a result of its retrotransposition. In addition, the MII oocyte-specific MTC-Dicer1 isoform is strongly repressed in aged oocytes. The MTC-Dicer1 encodes an N-terminally truncated Dicer isoform that governs the transposon surveillance through post-transcriptional silencing by RNAi. These findings suggest that altered retrotransposon expression and retrotransposon-mediated gene regulation in aged oocytes could functionally promote reproductive aging.
Using genomics, mouse genetics, cell and molecular biology, we propose to investigate the importance of retrotransposons in female reproductive aging. We will:
1) Profile retrotransposons and retrotransposon-dependent gene regulation in young and old oocytes and somatic granulosa cells.
2) Investigate the importance of aberrant retrotransposon induction and retrotransposition during reproductive aging.
3) Investigate the importance of retrotransposon-mediated gene regulation in reproductive aging.
Taken together, the proposed studies will provide new insights into the cellular and molecular mechanisms that govern female reproductive aging and will add a new dimension to our understanding of retrotransposon functions in development and disease.
Nearly 40% of the mammalian genome originates from retrotransposons. Most mammalian retrotransposons are strictly silenced in development and physiology. However, induction of specific retrotransposons can be observed in normal oocytes and preimplantation embryos. Interestingly, a subset of retrotransposons confers a gene regulatory role, at least in part, by acting as alternative promoters, exons, and polyadenylation signals to regulate proximal protein-coding genes. Such retrotransposon-dependent gene regulation frequently alters gene structure and/or gene expression and has been shown in our preliminary studies to play important developmental functions in oocyte biology and preimplantation development.
Female reproductive aging presents an excellent experimental system to probe the functional importance of retrotransposons in aging. Unlike somatic tissues, which strongly repress retrotransposon expression, oocytes and preimplantation embryos exhibit a strong induction of specific retrotransposons, possibly due to extensive epigenetic reprogramming during these unique developmental stages. Our preliminary studies show that aged oocytes exhibit expression alteration of specific retrotransposons, as well as RT:gene isoforms. Interestingly, the IAPEY4 family, which is retrotransposition-competent, is strongly induced in aged oocytes. IAPEY4 induction could lead to DNA damage and innate immune response in aged oocytes as a result of its retrotransposition. In addition, the MII oocyte-specific MTC-Dicer1 isoform is strongly repressed in aged oocytes. The MTC-Dicer1 encodes an N-terminally truncated Dicer isoform that governs the transposon surveillance through post-transcriptional silencing by RNAi. These findings suggest that altered retrotransposon expression and retrotransposon-mediated gene regulation in aged oocytes could functionally promote reproductive aging.
Using genomics, mouse genetics, cell and molecular biology, we propose to investigate the importance of retrotransposons in female reproductive aging. We will:
1) Profile retrotransposons and retrotransposon-dependent gene regulation in young and old oocytes and somatic granulosa cells.
2) Investigate the importance of aberrant retrotransposon induction and retrotransposition during reproductive aging.
3) Investigate the importance of retrotransposon-mediated gene regulation in reproductive aging.
Taken together, the proposed studies will provide new insights into the cellular and molecular mechanisms that govern female reproductive aging and will add a new dimension to our understanding of retrotransposon functions in development and disease.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Berkeley,
California
947200001
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 367% from $651,426 to $3,043,130.
Regents Of The University Of California was awarded
Retrotransposons in Female Reproductive Aging: Insights & Mechanisms
Project Grant R01AG078958
worth $3,043,130
from National Institute on Aging in September 2022 with work to be completed primarily in Berkeley California United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.866 Aging Research.
The Project Grant was awarded through grant opportunity Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 5/21/26
Period of Performance
9/1/22
Start Date
5/31/27
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01AG078958
Transaction History
Modifications to R01AG078958
Additional Detail
Award ID FAIN
R01AG078958
SAI Number
R01AG078958-3950081920
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NN00 NIH National Insitute on Aging
Awardee UEI
GS3YEVSS12N6
Awardee CAGE
50853
Performance District
CA-12
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute on Aging, National Institutes of Health, Health and Human Services (075-0843) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,272,415 | 100% |
Modified: 5/21/26